NAGE earnings: a negative outcome, -9.7%

On March 14, 2022, Niagen Bioscience, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.7% in the window around the event. It had already run -14.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.